Reimbursement News, In Brief
Executive Summary
Senate Republicans question incentive payments for the meaningful use of electronic health records; wholesaler H.D. Smith plans Pacific Northwest expansion; chemo parity bill in California fails again; CVS settles Part D false claims charges; NCPA releases independent pharmacy trends report.
You may also be interested in...
House Committee Leaders Want EHR Incentive Payments Paused Until Standards Are Strengthened
GOP leaders of the Energy & Commerce and Ways & Means committees ask CMS to halt incentive payments for meaningful use of electronic health records until true interoperable standards are developed and the criteria for demonstrating meaningful use are strengthened.
CVS Caremark To Pay FTC $5 Million To Resolve First Medicare Part D Deceptive Pricing Case
The Federal Trade Commission claims a CVS subsidiary posted prices for Rx drugs at CVS and Walgreens pharmacies that were as much as ten times less than the actual prices, pushing consumers into the donut hole more quickly.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.